Schwartz, Z <br/><br/>
Treatment of resting zone chondrocytes with transforming growth factor-beta 1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.  [electronic resource] 

 -  Bone  Nov 1998 
 - 465-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>8756-3282 
<br/><br/><label>Standard No.: </label>10.1016/s8756-3282(98)00132-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>24,25-Dihydroxyvitamin D 3--pharmacology<br/>Alkaline Phosphatase--metabolism<br/>Animals<br/>Calcitriol--pharmacology<br/>Cell Differentiation--drug effects<br/>Cells, Cultured<br/>Chondrocytes--cytology<br/>Collagen--metabolism<br/>Dose-Response Relationship, Drug<br/>Down-Regulation--physiology<br/>Drug Synergism<br/>Phenotype<br/>Rats<br/>Rats, Sprague-Dawley<br/>Transforming Growth Factor beta--pharmacology<br/>Up-Regulation--physiology